(Total Views: 675)
Posted On: 04/24/2019 8:22:04 AM
Post# of 594
How about an announced report to investigate the commercialization of Hemostyp............
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp(R) in Support of Soci
8:00 AM ET 4/24/19 | GlobeNewswire
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp(R) in Support of Société Générale's Strategic Review
HENDERSON, Nev., April 24, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), ("UHP" or "the company"
, manufacturer and marketer of HemoStyp(R) , a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it had retained IQVIA Inc. to conduct a U.S. market commercialization study for HemoStyp. The primary purpose of the study will be to assist the company and Société Générale in its previously announced Review of Strategic Alternatives (https://www.unitedhealthproductsinc.com/press-releases/2018/11/28/united-health-products-united-health-engages-socit-gnrale-to-undertake-strategic-review). In addition, IQVIA will perform qualitative primary market research, and do medical device supply audits using its proprietary databases. IQVIA's work is expected to be completed in the near future.
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp(R) in Support of Soci
8:00 AM ET 4/24/19 | GlobeNewswire
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp(R) in Support of Société Générale's Strategic Review
HENDERSON, Nev., April 24, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), ("UHP" or "the company"
, manufacturer and marketer of HemoStyp(R) , a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it had retained IQVIA Inc. to conduct a U.S. market commercialization study for HemoStyp. The primary purpose of the study will be to assist the company and Société Générale in its previously announced Review of Strategic Alternatives (https://www.unitedhealthproductsinc.com/press-releases/2018/11/28/united-health-products-united-health-engages-socit-gnrale-to-undertake-strategic-review). In addition, IQVIA will perform qualitative primary market research, and do medical device supply audits using its proprietary databases. IQVIA's work is expected to be completed in the near future.
(0)
(0)
